Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre Phase 2b Randomised Controlled Trial Investigating the Efficacy and Safety of Intravenous Paracetamol in Reducing Core Body Temperature After Traumatic Brain Injury

NCT01231139 is registered in ClinicalTrials.gov with Dr. M.K. Saxena as lead sponsor.

NCT NCT01231139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01231139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre Phase 2b Randomised Controlled Trial Investigating the Efficacy and Safety of Intravenous Paracetamol in Reducing Core Body Temperature After Traumatic Brain Injury
Lead sponsor
Dr. M.K. Saxena
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2010
Completion date
June 30, 2014
Enrollment
41 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury